BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim TH, Lim MC, Kim SI, Seo SS, Kim SH, Park SY. Preoperative Prediction of Cardiophrenic Lymph Node Metastasis in Advanced Ovarian Cancer Using Computed Tomography. Ann Surg Oncol 2016;23:1302-8. [PMID: 26714941 DOI: 10.1245/s10434-015-5015-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Lee IO, Lee JY, Kim HJ, Nam EJ, Kim S, Kim SW, Lee CY, Kang WJ, Kim YT. Prognostic significance of supradiaphragmatic lymph node metastasis detected by 18F-FDG PET/CT in advanced epithelial ovarian cancer. BMC Cancer 2018;18:1165. [PMID: 30477469 DOI: 10.1186/s12885-018-5067-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
2 Salehi S, Mohammar R, Suzuki C, Joneborg U, Hjerpe E, Torbrand C, Falconer H. Cardiophrenic lymph node resection in advanced ovarian cancer: surgical outcomes, pre- and postoperative imaging. Acta Oncol 2018;57:820-4. [PMID: 29182048 DOI: 10.1080/0284186X.2017.1409434] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
3 Prader S, Harter P, Grimm C, Traut A, Waltering K, Alesina PF, Heikaus S, Ataseven B, Heitz F, Schneider S, du Bois A. Surgical management of cardiophrenic lymph nodes in patients with advanced ovarian cancer. Gynecologic Oncology 2016;141:271-5. [DOI: 10.1016/j.ygyno.2016.03.012] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.8] [Reference Citation Analysis]
4 Lopes A, Rangel Costa RL, di Paula R, Anton C, Calheiros Y, Sartorelli V, Kanashiro YM, de Lima JA, Yamada A, Pinto GLS, Vianna MR, Nogueira Dias Genta ML, Ribeiro U Jr, Dos Santos MO. Cardiophrenic lymph node resection in cytoreduction for primary advanced or recurrent epithelial ovarian carcinoma: a cohort study. Int J Gynecol Cancer 2019;29:188-94. [PMID: 30640703 DOI: 10.1136/ijgc-2018-000073] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
5 Cowan RA, Tseng J, Murthy V, Srivastava R, Long Roche KC, Zivanovic O, Gardner GJ, Chi DS, Park BJ, Sonoda Y. Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer. Gynecol Oncol 2017;147:262-6. [PMID: 28888540 DOI: 10.1016/j.ygyno.2017.09.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
6 Engbersen MP, Van Driel W, Lambregts D, Lahaye M. The role of CT, PET-CT, and MRI in ovarian cancer. Br J Radiol 2021;94:20210117. [PMID: 34415198 DOI: 10.1259/bjr.20210117] [Reference Citation Analysis]
7 Ai Y, Zhang J, Jin J, Zhang J, Zhu H, Jin X. Preoperative Prediction of Metastasis for Ovarian Cancer Based on Computed Tomography Radiomics Features and Clinical Factors. Front Oncol 2021;11:610742. [PMID: 34178617 DOI: 10.3389/fonc.2021.610742] [Reference Citation Analysis]
8 Laasik M, Kemppainen J, Auranen A, Hietanen S, Grénman S, Seppänen M, Hynninen J. Behavior of FDG-avid supradiaphragmatic lymph nodes in PET/CT throughout primary therapy in advanced serous epithelial ovarian cancer: a prospective study. Cancer Imaging 2019;19:27. [PMID: 31142357 DOI: 10.1186/s40644-019-0215-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Minig L, Arraras M, Zorrero C, Martinez P, Patron M, Peñalver JC. A different surgical approach for cardiophrenic lymph node resection in advanced ovarian cancer. Ecancermedicalscience 2017;11:780. [PMID: 29225687 DOI: 10.3332/ecancer.2017.780] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
10 McIntosh LJ, O'Neill AC, Bhanusupriya S, Matalon SA, Van den Abbeele AD, Ramaiya NH, Shinagare AB. Prognostic significance of supradiaphragmatic lymph nodes at initial presentation in patients with stage III high-grade serous ovarian cancer. Abdom Radiol (NY) 2017;42:2513-20. [PMID: 28429056 DOI: 10.1007/s00261-017-1158-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
11 Mert I, Kumar A, Sheedy SP, Weaver AL, McGree ME, Kim B, Cliby WA. Clinical significance of enlarged cardiophrenic lymph nodes in advanced ovarian cancer: Implications for survival. Gynecol Oncol 2018;148:68-73. [PMID: 29129390 DOI: 10.1016/j.ygyno.2017.10.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
12 Kengsakul M, Nieuwenhuyzen-de Boer GM, Bijleveld AHJ, Udomkarnjananun S, Kerr SJ, Niehot CD, van Beekhuizen HJ. Survival in Advanced-Stage Epithelial Ovarian Cancer Patients with Cardiophrenic Lymphadenopathy Who Underwent Cytoreductive Surgery: A Systematic Review and Meta-Analysis. Cancers (Basel) 2021;13:5017. [PMID: 34638501 DOI: 10.3390/cancers13195017] [Reference Citation Analysis]
13 Martínez-gómez C, Angeles MA, Leray H, Tanguy Le Gac Y, Ferron G, Martinez A. Transdiaphragmatic and transxiphoid cardiophrenic lymph node resection step-by-step in advanced ovarian cancer. Int J Gynecol Cancer 2020;30:1646-7. [DOI: 10.1136/ijgc-2020-001737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Pinelli C, Morotti M, Casarin J, Tozzi R, Alazzam M, Mavroeidis VK, Soleymani Majd H. The Feasibility of Cardiophrenic Lymphnode Assessment and Removal in Patients Requiring Diaphragmatic Resection During Interval Debulking Surgery for Ovarian Cancer. J Invest Surg 2021;34:756-62. [PMID: 31809609 DOI: 10.1080/08941939.2019.1690077] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
15 Nuruzzaman HSM, Tan GHC, Nadarajah R, Teo M. Relevance of enlarged cardiophrenic lymph nodes in determining prognosis of patients with advanced ovarian cancer. BMJ Case Rep 2018;2018:bcr-2017-221450. [PMID: 29331996 DOI: 10.1136/bcr-2017-221450] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Forstner R, Meissnitzer M, Cunha TM. Update on Imaging of Ovarian Cancer. Curr Radiol Rep 2016;4:31. [PMID: 27110476 DOI: 10.1007/s40134-016-0157-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
17 Larish A, Mert I, McGree M, Weaver A, Sheedy S, Cilby W. Recurrence patterns in patients with abnormal cardiophrenic lymph nodes at ovarian cancer diagnosis. Int J Gynecol Cancer 2020;30:504-8. [PMID: 31953350 DOI: 10.1136/ijgc-2019-000981] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Chen HZ, Wang XR, Zhao FM, Chen XJ, Li XS, Ning G, Guo YK. The Development and Validation of a CT-Based Radiomics Nomogram to Preoperatively Predict Lymph Node Metastasis in High-Grade Serous Ovarian Cancer. Front Oncol 2021;11:711648. [PMID: 34532289 DOI: 10.3389/fonc.2021.711648] [Reference Citation Analysis]
19 Prader S, Vollmar N, du Bois A, Heitz F, Schneider S, Ataseven B, Bommert M, Waltering K, Heikaus S, Koch JA, Alesina PF, Traut A, Harter P. Pattern and impact of metastatic cardiophrenic lymph nodes in advanced epithelial ovarian cancer. Gynecologic Oncology 2019;152:76-81. [DOI: 10.1016/j.ygyno.2018.11.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
20 Garbi A, Zanagnolo V, Colombo N, Aletti G, Achilarre MT, Bocciolone L, Landoni F, Rizzo S, Biffi R, Maggioni A. Feasibility of Transabdominal Cardiophrenic Lymphnode Dissection in Advanced Ovarian Cancer: Initial Experience at a Tertiary Center. Int J Gynecol Cancer 2017;27:1268-73. [PMID: 28498236 DOI: 10.1097/IGC.0000000000000983] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
21 Luger AK, Steinkohl F, Aigner F, Jaschke W, Marth C, Zeimet AG, Reimer D. Enlarged cardiophrenic lymph nodes predict disease involvement of the upper abdomen and the outcome of primary surgical debulking in advanced ovarian cancer. Acta Obstet Gynecol Scand 2020;99:1092-9. [PMID: 32112653 DOI: 10.1111/aogs.13835] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]